Next Generation News and Research

RSS

Research: Gene behind epilepsy syndrome could play a key role in other idiopathic epilepsies

Researchers at the University Department of Neurology at the MedUni Vienna have identified a gene behind an epilepsy syndrome, which could also play an important role in other idiopathic (genetically caused) epilepsies.

18 Apr 2013

New combination therapies with anti-sickling capabilities needed for sickle cell disease

Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.

18 Apr 2013

Two abstracts related to Advaxis' ADXS-HPV selected for poster presentation at ASCO meeting

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that two abstracts related to ADXS-HPV (ADXS11-001), the Company's lead clinical stage product candidate, have been selected for poster presentation at the 2013 American Society of Clinical Oncology Annual Meeting in Chicago, IL, from May 31 - June 4, 2013, at the McCormick Place Convention Center.

18 Apr 2013

Animal medication studies may lead way in discovering new drugs to relieve human suffering

It's been known for decades that animals such as chimpanzees seek out medicinal herbs to treat their diseases. But in recent years, the list of animal pharmacists has grown much longer, and it now appears that the practice of animal self-medication is a lot more widespread than previously thought, according to a University of Michigan ecologist and his colleagues.

18 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

With Bio-patch sensor, health care can be moved into home, researcher says

The future of health care could be found in a tiny, paper-thin skin patch that collects vital information. The Bio-patch sensor developed by researchers at Stockholm's KTH Royal Institute of Technology is inexpensive, versatile and, best of all, comfortable to wear.

17 Apr 2013

High levels of blood cholesterol increase risk of AD and heart disease

Researchers at the Linda Crnic Institute for Down Syndrome and the University of Colorado School of Medicine have found that a single mechanism may underlie the damaging effect of cholesterol on the brain and on blood vessels.

16 Apr 2013

ACS releases limited-edition book on improving surgical health care

Today, the American College of Surgeons released a limited-edition book, Inspiring Quality Tour: Lessons Learned in the Pursuit of Quality Surgical Health Care, in conjunction with its annual Leadership and Advocacy Summit in Washington, DC.

16 Apr 2013

Researchers identify gene mutations responsible for subtype of childhood brain tumor

The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients.

15 Apr 2013

Ozone attacks lung surface fluids, causes severe respiratory problems

Research at Birkbeck, University of London uses world-leading neutron sources at ILL and ISIS to demonstrate ozone attacks on lung surface fluids.

12 Apr 2013

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

Research on a soy-based treatment for colorectal cancer, a promising agent in ovarian cancer, and a new drug target for advanced prostate cancer was presented at the American Association for Cancer Research 2013 Annual Meeting.

12 Apr 2013

New data on use of PBD dimers as warheads in ADCs presented at AACR annual meeting

Spirogen, a leading oncology-focused company developing DNA sequence targeted agents, and BioAtla LLC, a San Diego headquartered antibody therapeutics developer, today announced new data on the use of pyrrolobenzodiazepine (PBD) dimers as warheads in antibody drug conjugates (ADCs) at the annual meeting of the American Association for Cancer Research (AACR) in Washington, DC.

11 Apr 2013

First-in-humans study introduces next generation cell therapy for heart failure patients

Translating a Mayo Clinic stem-cell discovery, an international team has demonstrated that therapy with cardiopoietic (cardiogenically-instructed) or "smart" stem cells can improve heart health for people suffering from heart failure.

11 Apr 2013

MedeAnalytics' Accountable Care Solution selected for Mississippi's MEHRS application

MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that the State of Mississippi Medicaid has selected MedeAnalytics' Accountable Care Solution to empower the next generation of the state's Medicaid Electronic Health Records System application.

9 Apr 2013

Experts outline challenges, opportunities of using social media in clinical care setting

As social media drastically alters the world we live in, physicians are left wondering what their role is in the digital revolution. In the first comprehensive review of its kind, experts at the George Washington University School of Medicine and Health Sciences have outlined the challenges and opportunities of using social media in a clinical care setting.

9 Apr 2013

Mammalian target of rapamycin (mTOR) pathway: an interview with Dr. Paul Mischel, Ludwig Institute for Cancer Research

The mammalian target of rapamycin, mTOR is a central integrator of the cell that coordinates growth factor receptor signaling with energy and nutrient status to control a wide array of activities, including the regulation of cellular proliferation and survival.

9 Apr 2013

Viewpoints: Drugging soldiers; GOP opposition to Medicaid expansion strays from party legacy; Health law distorts market

Last year, more active-duty soldiers committed suicide than died in battle. ... Worse, according to data not reported on until now, the military evidently responded to stress that afflicts soldiers in Iraq and Afghanistan primarily by drugging soldiers on the front lines.

9 Apr 2013

GE Healthcare releases next-generation sequencing assay for use in clinical trials

GE Healthcare announced today that Clarient Diagnostic Services, Inc., a GE Healthcare company, will begin offering a next-generation sequencing assay focused on solid tumor targets for use in clinical trials.

8 Apr 2013

Lipocine announces favorable Phase I study results for LPCN 1111

Lipocine Inc., a biopharmaceutical company focused on developing innovative oral hormone therapies for men's and women's health, today announced favorable Phase I results for LPCN 1111.

8 Apr 2013

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).

8 Apr 2013

Next Generation News and Research

Research: Gene behind epilepsy syndrome could play a key role in other idiopathic epilepsies

New combination therapies with anti-sickling capabilities needed for sickle cell disease

Two abstracts related to Advaxis' ADXS-HPV selected for poster presentation at ASCO meeting

Animal medication studies may lead way in discovering new drugs to relieve human suffering

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

With Bio-patch sensor, health care can be moved into home, researcher says

High levels of blood cholesterol increase risk of AD and heart disease

ACS releases limited-edition book on improving surgical health care

Researchers identify gene mutations responsible for subtype of childhood brain tumor

Ozone attacks lung surface fluids, causes severe respiratory problems

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

New data on use of PBD dimers as warheads in ADCs presented at AACR annual meeting

First-in-humans study introduces next generation cell therapy for heart failure patients

MedeAnalytics' Accountable Care Solution selected for Mississippi's MEHRS application

Experts outline challenges, opportunities of using social media in clinical care setting

Mammalian target of rapamycin (mTOR) pathway: an interview with Dr. Paul Mischel, Ludwig Institute for Cancer Research

Viewpoints: Drugging soldiers; GOP opposition to Medicaid expansion strays from party legacy; Health law distorts market

GE Healthcare releases next-generation sequencing assay for use in clinical trials

Lipocine announces favorable Phase I study results for LPCN 1111

Sorrento Therapeutics, IGDRASOL to present updates on Cynviloq at Nanomedicine 2013 meeting

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News